scispace - formally typeset
K

Kylie Thaler

Researcher at Danube University Krems

Publications -  47
Citations -  1732

Kylie Thaler is an academic researcher from Danube University Krems. The author has contributed to research in topics: Randomized controlled trial & Cochrane Library. The author has an hindex of 20, co-authored 46 publications receiving 1432 citations.

Papers
More filters
Journal ArticleDOI

The GRADE approach is reproducible in assessing the quality of evidence of quantitative evidence syntheses

TL;DR: It is suggested that trained individuals using the GRADE approach improves reliability in comparison to intuitive judgments about the QoE and that two individual raters can reliably assess theQoE using the Grading of Recommendations, Assessment, Development, and Evaluation system.
Journal ArticleDOI

Socioeconomic inequalities in non-communicable diseases and their risk factors: an overview of systematic reviews.

TL;DR: Having low socioeconomic status (SES) and/or living in low and middle income countries (LMIC) increased the risk of developing cardiovascular diseases (CVD), lung and gastric cancer, type 2 diabetes, and chronic obstructive pulmonary disease (COPD) and low SES increased therisk of mortality from lung cancer, COPD, and reduced breast cancer survival in HIC.
Journal ArticleDOI

Information overload in healthcare: too much of a good thing?

TL;DR: This work discusses the issues faced by three major actors of the healthcare system: patients, healthcare practitioners, and systematic reviewers through the concept of "filter failure", positing that the main problem is not that there is "too much information", but that the traditional means of managing and evaluating information are ill-suited to the realities of the digital age.
Journal ArticleDOI

Antidepressants for the treatment of abdominal pain-related functional gastrointestinal disorders in children and adolescents

TL;DR: A systematic review of double-blind, randomised controlled trials of antidepressants for treatment of abdominal pain-related FGIDs in children and adolescents found no statistically significant differences between amitriptyline and placebo and no clear conclusions on the risks of harms can be drawn.